Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KMS Kammermann Monitoring Services is a Swiss contract research organization (CRO) that provides specialized clinical trial services to the pharmaceutical, biotechnology, and medical device sectors. Established in 2004 and headquartered in Baar, the company offers a broad range of solutions including clinical monitoring, project management, regulatory affairs, and quality assurance. KMS focuses on Phase I through IV clinical trials, ensuring that studies are conducted in strict accordance with international Good Clinical Practice (GCP) guidelines. The firm is particularly well-regarded for its deep expertise in the DACH region, helping clients navigate local regulatory requirements and site management. By providing tailored monitoring strategies, KMS supports both small-scale biotech startups and established global healthcare companies in their clinical development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KMS Kammermann Monitoring Services.